Tech Company Financing Transactions
Rimidi Funding Round
Rimidi, operating out of Atlanta, secured $6.6 million from Cox Enterprises, Joint Admissions and Matriculation Board and Lilly Ventures.
Transaction Overview
Company Name
Announced On
7/12/2018
Transaction Type
Venture Equity
Amount
$6,575,000
Round
Series A
Investors
Proceeds Purpose
The Series A-1 financing will fuel Rimidi's growth and accelerate its market penetration. Formerly known as Rimidi Diabetes, Inc., the Company is rebranding to Rimidi, Inc. to reflect the expansion of its platform and mission to broadly address cardiometabolic disease.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
75 5th St. NW Tech Square 2250
Atlanta, GA 30308
USA
Atlanta, GA 30308
USA
Phone
Undisclosed
Website
Email Address
Overview
The Rimidi leadership team is comprised of physicians, bioengineers and business professionals credited with developing technologies and practices successfully used in healthcare today.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Lucienne Ide
Chief Executive Officer
Joshua Claman
Chief Technical Officer
Chris McIlvoy
VP - General Counsel
Jennifer Ide
VP - Operations
Tara Davis
Browse more venture capital transactions:
Prev: 7/12/2018: Double Helix Optics venture capital transaction
Next: 7/12/2018: monday.com venture capital transaction
Share this article
News on VC Transactions
Our team works diligently to report on all VC transactions involving tech companies. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs